Skip to content

Novel Short-Term Prognostic Score for HBV-Related ACLF Patients Receiving Artificial Liver Therapy: A Real-World Cohort Study

Novel Short-Term Prognostic Score for HBV-Related ACLF Patients Receiving Artificial Liver Therapy: A Real-World Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105426
Enrollment
Unknown
Registered
2025-07-03
Start date
2025-08-31
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute-on-chronic liver failure

Interventions

Artificial liver treatment Group 1 (Prospective cohort):None
Artificial liver treatment Group 2 (Retrospective cohort):None

Sponsors

Ganzhou Fifth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. According to the COSSH diagnostic criteria of the Chinese Guidelines for the Diagnosis and Treatment of Liver Failure (2024 Edition), patients diagnosed with hepatitis B-related ACLF: total bilirubin >=12 mg/dL (205 µmol/L) and INR>=1.5 were diagnosed with acute liver failure of hepatitis B; And artificial liver treatment was performed (for prospective enrolled patients who did not receive artificial liver treatment in other hospitals before enrollment).

Exclusion criteria

Exclusion criteria: 1. Presence of any organ tumors; 2. Have a history of organ transplantation; 3. Patients who are not infected with HBV; 4. Incomplete 90-day follow-up.

Design outcomes

Primary

MeasureTime frame
Case fatality rate;AIC/BIC;AUC;Model calibration evaluation;Evaluation of model clinical applicability;

Secondary

MeasureTime frame
The number of artificial liver treatments;Incidence of complications;

Countries

China

Contacts

Public ContactLuo Yingmin

Ganzhou Fifth People's Hospital

540982830@qq.com+86 159 7007 3354

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026